Does ROZANOLIXIZUMAB Cause Therapeutic response shortened? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Therapeutic response shortened have been filed in association with ROZANOLIXIZUMAB (RYSTIGGO). This represents 7.3% of all adverse event reports for ROZANOLIXIZUMAB.
22
Reports of Therapeutic response shortened with ROZANOLIXIZUMAB
7.3%
of all ROZANOLIXIZUMAB reports
0
Deaths
6
Hospitalizations
How Dangerous Is Therapeutic response shortened From ROZANOLIXIZUMAB?
Of the 22 reports, 6 (27.3%) required hospitalization.
Is Therapeutic response shortened Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROZANOLIXIZUMAB. However, 22 reports have been filed with the FAERS database.
What Other Side Effects Does ROZANOLIXIZUMAB Cause?
Myasthenia gravis (158)
Headache (64)
Drug ineffective (54)
Diarrhoea (41)
Asthenia (36)
Fatigue (34)
Dyspnoea (29)
Nausea (25)
Fall (22)
Pyrexia (19)
What Other Drugs Cause Therapeutic response shortened?
DUPILUMAB (6,720)
ADALIMUMAB (2,597)
INFLIXIMAB-DYYB (1,837)
INFLIXIMAB (1,231)
SECUKINUMAB (1,097)
RISANKIZUMAB-RZAA (1,089)
CARBIDOPA\LEVODOPA (1,027)
ONABOTULINUMTOXINA (907)
ERENUMAB-AOOE (805)
CERTOLIZUMAB PEGOL (687)
Which ROZANOLIXIZUMAB Alternatives Have Lower Therapeutic response shortened Risk?
ROZANOLIXIZUMAB vs ROZANOLIXIZUMAB-NOLI
ROZANOLIXIZUMAB vs RUBIDIUM RB-82
ROZANOLIXIZUMAB vs RUCAPARIB
ROZANOLIXIZUMAB vs RUCAPARIB CAMSYLATE
ROZANOLIXIZUMAB vs RUFINAMIDE